Literature DB >> 28068321

Analysis of DNA methylation in single circulating tumor cells.

C F Pixberg1, K Raba2, F Müller1, B Behrens1, E Honisch3, D Niederacher3, H Neubauer3, T Fehm3, W Goering4, W A Schulz4, P Flohr5,6, G Boysen5,6, M Lambros5,6, J S De Bono5,6, W T Knoefel1, C Sproll7, N H Stoecklein1, R P L Neves1.   

Abstract

Direct analysis of circulating tumor cells (CTCs) can inform on molecular mechanisms underlying systemic spread. Here we investigated promoter methylation of three genes regulating epithelial-to-mesenchymal transition (EMT), a key mechanism enabling epithelial tumor cells to disseminate and metastasize. For this, we developed a single-cell protocol based on agarose-embedded bisulfite treatment, which allows investigating DNA methylation of multiple loci via a multiplex PCR (multiplexed-scAEBS). We established our assay for the simultaneous analysis of three EMT-associated genes miR-200c/141, miR-200b/a/429 and CDH1 in single cells. The assay was validated in solitary cells of GM14667, MDA-MB-231 and MCF-7 cell lines, achieving a DNA amplification efficiency of 70% with methylation patterns identical to the respective bulk DNA. Then we applied multiplexed-scAEBS to 159 single CTCs from 11 patients with metastatic breast and six with metastatic castration-resistant prostate cancer, isolated via CellSearch (EpCAMpos/CKpos/CD45neg/DAPIpos) and subsequent FACS sorting. In contrast to CD45pos white blood cells isolated and processed by the identical approach, we observed in the isolated CTCs methylation patterns resembling more those of epithelial-like cells. Methylation at the promoter of microRNA-200 family was significantly higher in prostate CTCs. Data from our single-cell analysis revealed an epigenetic heterogeneity among CTCs and indicates tumor-specific active epigenetic regulation of EMT-associated genes during blood-borne dissemination.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28068321     DOI: 10.1038/onc.2016.480

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  75 in total

1.  M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis.

Authors:  Elisabetta Rossi; Umberto Basso; Romina Celadin; Francesca Zilio; Salvatore Pucciarelli; Michele Aieta; Carmen Barile; Teodoro Sava; Giorgio Bonciarelli; Salvatore Tumolo; Cristina Ghiotto; Cristina Magro; Antonio Jirillo; Stefano Indraccolo; Alberto Amadori; Rita Zamarchi
Journal:  Clin Cancer Res       Date:  2010-10-26       Impact factor: 12.531

Review 2.  Single-cell epigenomics: techniques and emerging applications.

Authors:  Omer Schwartzman; Amos Tanay
Journal:  Nat Rev Genet       Date:  2015-10-13       Impact factor: 53.242

3.  Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.

Authors:  Eduardo F Farias; Kevin Petrie; Boris Leibovitch; Janice Murtagh; Manuel Boix Chornet; Tino Schenk; Arthur Zelent; Samuel Waxman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

4.  Detection and phenotyping of circulating tumor cells in high-risk localized prostate cancer.

Authors:  Sumanta K Pal; Miaoling He; Timothy Wilson; Xueli Liu; Keqiang Zhang; Courtney Carmichael; Alejandra Torres; Sonya Hernandez; Clayton Lau; Neeraj Agarwal; Mark Kawachi; Yun Yen; Jeremy O Jones
Journal:  Clin Genitourin Cancer       Date:  2014-09-22       Impact factor: 2.872

5.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

6.  SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer.

Authors:  Maria Chimonidou; Areti Strati; Nikos Malamos; Vasilis Georgoulias; Evi S Lianidou
Journal:  Clin Chem       Date:  2012-11-07       Impact factor: 8.327

7.  Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.

Authors:  Maria Spiliotaki; Dimitris Mavroudis; Kyriaki Kapranou; Harris Markomanolaki; Galatea Kallergi; Filippos Koinis; Kostas Kalbakis; Vassilis Georgoulias; Sofia Agelaki
Journal:  Breast Cancer Res       Date:  2014-11-29       Impact factor: 6.466

8.  Classification of circulating tumor cells by epithelial-mesenchymal transition markers.

Authors:  Shiyang Wu; Suyan Liu; Zhiming Liu; Jiefeng Huang; Xiaoyu Pu; Jing Li; Dinghua Yang; Haijun Deng; Ning Yang; Jiasen Xu
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

9.  Molecular profiling of single circulating tumor cells with diagnostic intention.

Authors:  Bernhard Polzer; Gianni Medoro; Sophie Pasch; Francesca Fontana; Laura Zorzino; Aurelia Pestka; Ulrich Andergassen; Franziska Meier-Stiegen; Zbigniew T Czyz; Barbara Alberter; Steffi Treitschke; Thomas Schamberger; Maximilian Sergio; Giulia Bregola; Anna Doffini; Stefano Gianni; Alex Calanca; Giulio Signorini; Chiara Bolognesi; Arndt Hartmann; Peter A Fasching; Maria T Sandri; Brigitte Rack; Tanja Fehm; Giuseppe Giorgini; Nicolò Manaresi; Christoph A Klein
Journal:  EMBO Mol Med       Date:  2014-11       Impact factor: 12.137

10.  Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

Authors:  Ellen Heitzer; Martina Auer; Christin Gasch; Martin Pichler; Peter Ulz; Eva Maria Hoffmann; Sigurd Lax; Julie Waldispuehl-Geigl; Oliver Mauermann; Carolin Lackner; Gerald Höfler; Florian Eisner; Heinz Sill; Hellmut Samonigg; Klaus Pantel; Sabine Riethdorf; Thomas Bauernhofer; Jochen B Geigl; Michael R Speicher
Journal:  Cancer Res       Date:  2013-03-07       Impact factor: 12.701

View more
  28 in total

Review 1.  Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development.

Authors:  Abhijit Pal; Rajiv Shinde; Manuel Selvi Miralles; Paul Workman; Johann de Bono
Journal:  Nat Rev Clin Oncol       Date:  2021-03-24       Impact factor: 66.675

Review 2.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

Review 3.  Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Authors:  Sergej Skvortsov; Ira-Ida Skvortsova; Dean G Tang; Anna Dubrovska
Journal:  Stem Cells       Date:  2018-08-27       Impact factor: 6.277

Review 4.  Future of Liquid Biopsies With Growing Technological and Bioinformatics Studies: Opportunities and Challenges in Discovering Tumor Heterogeneity With Single-Cell Level Analysis.

Authors:  Naveen Ramalingam; Stefanie S Jeffrey
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

Review 5.  Analyzing Circulating Tumor Cells One at a Time.

Authors:  Veronica Ortiz; Min Yu
Journal:  Trends Cell Biol       Date:  2018-06-08       Impact factor: 20.808

Review 6.  Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells.

Authors:  Laura Keller; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2019-08-27       Impact factor: 60.716

Review 7.  Emerging epigenetic-modulating therapies in lymphoma.

Authors:  David Sermer; Laura Pasqualucci; Hans-Guido Wendel; Ari Melnick; Anas Younes
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

Review 8.  Leveraging Single-Cell Approaches in Cancer Precision Medicine.

Authors:  Aritro Nath; Andrea H Bild
Journal:  Trends Cancer       Date:  2021-02-06

Review 9.  Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities.

Authors:  Yu-Ping Yang; Teresa M Giret; Richard J Cote
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

10.  Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients.

Authors:  Theresa Benezeder; Verena Tiran; Alexandra A N Treitler; Christoph Suppan; Christopher Rossmann; Herbert Stoeger; Richard J Cote; Ram H Datar; Marija Balic; Nadia Dandachi
Journal:  Oncotarget       Date:  2017-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.